Literature DB >> 18227704

Appearance of melanocytic nevi on the backs of young Australian children: a 7-year longitudinal study.

Elizabeth Milne1, Julie A Simpson, Dallas R English.   

Abstract

To determine the rate of appearance of nevi in a cohort of children between ages 6 and 12 years. The number of nevi has been established as the strongest known risk factor for melanoma, but whether the rate at which nevi appear during childhood varies by age is not well understood. The study involved analysis of nevus development over time in a cohort of 640 Western Australian school children who formed the control group in the Kidskin intervention trial. Children were assessed at ages 6, 10 and 12 years, with nevi on the back counted from photographs. The changes in both number and density of nevi between ages 6 and 12 years were linear with respect to age. The number and density of nevi increased at a greater rate for boys compared with girls; for children with blue, hazel and green eyes compared with those with brown eyes; for blonde versus dark haired children and for children with heavy freckling compared with those with no freckles. In conclusion, further research is needed to determine whether the linear increase in nevi continues into adolescence. If so, it suggests that skin cancer prevention campaigns should target older children and adolescents as well as younger children. Longitudinal studies have important advantages over cross-sectional studies in the description of nevus development with age, and should be the preferred study design.

Entities:  

Mesh:

Year:  2008        PMID: 18227704     DOI: 10.1097/CMR.0b013e3282f20192

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  7 in total

1.  Cross-sectional analysis of the dermoscopic patterns and structures of melanocytic naevi on the back and legs of adolescents.

Authors:  M Fonseca; M A Marchetti; E Chung; S W Dusza; M E Burnett; A A Marghoob; A C Geller; M Bishop; A Scope; A C Halpern
Journal:  Br J Dermatol       Date:  2015-10-27       Impact factor: 9.302

Review 2.  The study of nevi in children: Principles learned and implications for melanoma diagnosis.

Authors:  Alon Scope; Michael A Marchetti; Ashfaq A Marghoob; Stephen W Dusza; Alan C Geller; Jaya M Satagopan; Martin A Weinstock; Marianne Berwick; Allan C Halpern
Journal:  J Am Acad Dermatol       Date:  2016-06-17       Impact factor: 11.527

3.  Factors in Early Adolescence Associated With a Mole-Prone Phenotype in Late Adolescence.

Authors:  Haoming Xu; Michael A Marchetti; Stephen W Dusza; Esther Chung; Maira Fonseca; Alon Scope; Alan C Geller; Marilyn Bishop; Ashfaq A Marghoob; Allan C Halpern
Journal:  JAMA Dermatol       Date:  2017-10-01       Impact factor: 10.282

4.  Effect of hair color and sun sensitivity on nevus counts in white children in Colorado.

Authors:  Jenny Aalborg; Joseph G Morelli; Tim E Byers; Stefan T Mokrohisky; Lori A Crane
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

5.  Trajectories of Nevus Development From Age 3 to 16 Years in the Colorado Kids Sun Care Program Cohort.

Authors:  Nancy L Asdigian; Anna E Barón; Joseph G Morelli; Stefan T Mokrohisky; Jenny Aalborg; Robert P Dellavalle; Matthew F Daley; Marianne Berwick; Keith E Muller; Neil F Box; Lori A Crane
Journal:  JAMA Dermatol       Date:  2018-11-01       Impact factor: 10.282

6.  Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system.

Authors:  Alon Scope; Stephen W Dusza; Ashfaq A Marghoob; Jaya M Satagopan; Juliana Braga Casagrande Tavoloni; Estee L Psaty; Martin A Weinstock; Susan A Oliveria; Marilyn Bishop; Alan C Geller; Allan C Halpern
Journal:  J Invest Dermatol       Date:  2011-05-12       Impact factor: 8.551

7.  Factors associated with nevus volatility in early adolescence.

Authors:  Susan A Oliveria; Alon Scope; Jaya M Satagopan; Alan C Geller; Stephen W Dusza; Martin A Weinstock; Marianne Berwick; Marilyn Bishop; Ashfaq A Marghoob; Allan C Halpern
Journal:  J Invest Dermatol       Date:  2014-04-14       Impact factor: 8.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.